MetaCap

Upexi Inc. (UPXI)

NASDAQ: UPXIFinanceFinance: Consumer ServicesUSD

0.4622-0.0861 (-15.70%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

UPXI stock chart

Technical analysis

Key statistics

All statistics
Market cap
$41.07M
EPS (TTM)
-$4.14
52-week range
0.4205 – 3.03
Day range
0.4205 – 0.54
Volume / Avg
2.14M / 3.02M
Beta
—

52-week range

$0.4205$3.03

UPXI stock today

On Nov 20, UPXI ended the session at $0.4622, shedding $0.0861 (15.70%), versus the S&P 500's 3.70% decline. At this level, UPXI sits near the bottom of its 52-week range of $0.4205 to $3.03: 84.7% below the high, set on Nov 25, 2025 and 9.9% above the low. UPXI is down 72.5% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 81.7%.

Upexi has posted a net loss over the last twelve months (EPS of -$4.14), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Upexi

Company profile

Upexi, Inc. engages in the development, manufacture, and distribution of consumer products. It offers nail grinder and pet supplements under the LuckyTail brand; energy solutions under the PRAX brand; and functional mushrooms under the Cure Mushrooms brand.

Sector
Finance
Industry
Finance: Consumer Services
CEO
Mr. Allan J. Marshall
Headquarters
Tampa, FL
Employees
10
IPO year
2021
Website
upexi.com

Financial highlights

Full financials

In fiscal 2026, Upexi generated $25.0 million in revenue, up 58.1% from fiscal 2025. Upexi reported a net loss of $246.1 million, compared with a loss of $13.7 million a year earlier. Gross margin was 89.5% (up from 68.7%) and operating margin -963.5%.

Upexi annual revenue, net income and EPS
Fiscal yearFY 2026FY 2025FY 2024FY 2023FY 2022
Revenue$25.00M$15.81M$26.00M$36.44M$23.07M
Growth+58.10%-39.19%-28.65%+57.99%-4.27%
Net income$-246.06M$-13.68M$-23.66M$-17.49M$-2.05M
EPS (diluted)$-3.87$-1.73$-23.03$-18.94$-0.43

Analyst forecast

Forecast

Consensus (1 analysts)

none

Avg. price target

$2.00+332.71%

  • Strong buy 0
  • Buy 1
  • Hold 0
  • Sell 0
  • Strong sell 0

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 10, 2026
EPS actual vs est.
$0.68 vs —

UPXI news

All UPXI news

Upexi peers

Finance sector
UPXI peer companies
CompanyPrice% ChgMarket capCompare
NCTYThe9 Limited American Depository Shares2.60-10.96%$39.71Mvs UPXI
CNFCNFinance Holdings Limited ADR2.33+12.56%$39.28Mvs UPXI
GRANGrande Group Limited Class A1.34+4.28%$42.86Mvs UPXI
MATHMetalpha Technology Holding Limited0.7611-13.21%$36.18Mvs UPXI
AUREAurelion Inc. Class A1.01-1.47%$34.84Mvs UPXI
BTCSBTCS Inc.0.653-12.23%$34.58Mvs UPXI
HYPDHyperion DeFi Inc.2.08-11.11%$31.72Mvs UPXI
SUIGSui Group Holdings Limited0.6591-11.05%$50.62Mvs UPXI

Indexes, lists and sector

Upexi stock FAQ

What is Upexi's stock price today?

UPXI last traded at $0.4622 as of Nov 20, 4:00 PM EST, down 15.70% on the day. Prices are delayed at least 15 minutes.

Does Upexi pay a dividend?

No. Upexi does not currently pay a regular cash dividend.

Who is Upexi's CEO?

Mr. Allan J. Marshall is the chief executive officer of Upexi Inc., which has about 10 employees.

Has UPXI ever split its stock?

Yes. The most recent UPXI stock split was a 1-for-20 split on Oct 3, 2024.

What is the UPXI 52-week high?

The 52-week high for UPXI is $3.03 and the 52-week low is $0.4205. The stock is currently 84.7% below its high.

Compare UPXI